What is Effector Therapeutics Inc (EFTR) stock price today?

Effector Therapeutics Inc (EFTR) currently trades at $0.00 per share. The stock has a market capitalization of $940.00 and a P/E ratio of —x.

Is EFTR stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Effector Therapeutics Inc has a Smart Value Score of 34/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Effector Therapeutics Inc's revenue and earnings?

Effector Therapeutics Inc has trailing twelve-month (TTM) revenue of $675000.00 with profit margins of 0.00%. Earnings per share (EPS) is $-12.57.

EFTR

Effector Therapeutics Inc

NASDAQ: EFTR · HEALTHCARE · BIOTECHNOLOGY

$0.00

+0.00% today

Updated 2026-04-30

Market cap

$940.00

P/E ratio

—

P/S ratio

69.65x

EPS (TTM)

$-12.57

Dividend yield

—

52W range

$0 – $0

Volume

0.0M

Market cap

$940.00

P/E ratio

—

P/S ratio

69.65x

EPS (TTM)

$-12.57

Dividend yield

—

52W range

$0 – $0

Volume

0.0M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

6.3

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$10.00

+4999900.00%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

+ Revenue growth 117.00% QoQ

Risks

- Thin margins at 0.00%

- Negative free cash flow $-7.28M

Key financials

Revenue Net Income Free Cash Flow

Metric	2020	2021	2022	2023	TTM
Revenue	$42.00M	$1.43M	$3.55M	$0.00	$675000.00
Net income	$14.21M	$15.80M	$-12.93M	$-35.81M	$-8.83M
EPS	—	—	—	—	$-12.57
Free cash flow	$13.68M	$-24.93M	$-26.09M	$-29.65M	$-7.28M
Profit margin	33.84%	1,104.76%	-363.83%	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
EFTR	$940.00	34	6.3	3.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Effector Therapeutics Inc trades at $0.00. Our Smart Value Score of 34/100 indicates the stock is weak. TTM revenue stands at $675000.00.

Frequently asked questions

What is Effector Therapeutics Inc's stock price?

Effector Therapeutics Inc (EFTR) trades at $0.00.

Is Effector Therapeutics Inc overvalued?

Smart Value Score 34/100 (Grade F, Strong Sell).

What is the price target of Effector Therapeutics Inc (EFTR)?

The analyst target price is $10.00, representing +4999900.0% upside from the current price of $0.00.

What is Effector Therapeutics Inc's revenue?

TTM revenue is $675000.00.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio69.65x

ROE-947.00%

Beta0.89

50D MA$0.00

200D MA$0.00

Shares out0.00B

Float0.00B

Short ratio—

Avg volume0.0M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

EFTR vs LLY →EFTR vs JNJ →EFTR vs ABBV →Stock screener →